Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population

Medicine (United States)

Volumn 95, Issue 52, 2016, Pages

  Van Der Linden, Noreen ^a   Klinkenberg, Lieke J J ^a   Bekers, Otto ^a   Van Loon, Luc J C ^b   Van Dieijen Visser, Marja P ^a   Zeegers, Maurice P ^c   Meex, Steven J R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarker; Cardiac troponin; Meta analysis; Mortality; Survival

Indexed keywords

TROPONIN; TROPONIN T; BIOLOGICAL MARKER; TROPONIN I;

ARTICLE; ASSAY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC VALUE; HIGH SENSITIVE CARDIAC TROPONIN I ASSAY; HIGH SENSITIVE CARDIAC TROPONIN T ASSAY; HUMAN; LIMIT OF QUANTITATION; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASE; MORTALITY; PREDICTIVE VALUE; RISK FACTOR;

BIOMARKERS; CARDIOVASCULAR DISEASES; HUMANS; MORTALITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TROPONIN I; TROPONIN T;

EID: 85010189144     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005703     Document Type: Article

References (38)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-98.
2. Al-Saleh A, Alazzoni A, Al Shalash S, et al. Performance of the highsensitivity troponin assay in diagnosing acute myocardial infarction: systematic review and meta-analysis. CMAJ Open 2014; 2: E199-207.
3. Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochemistry (Mosc) 2013; 78: 1447-65.
4. de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA 2013; 309: 2262-9.
5. Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 2013; 10: 623-34.
6. Collinson P. The role of cardiac biomarkers in cardiovascular disease risk assessment. Curr Opin Cardiol 2014; 29: 366-71.
7. Ahmed AN, Blonde K, Hackam D, et al. Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis. Ann Med 2014; 46: 653-63.
8. Michos ED, Wilson LM, Yeh HC, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Ann Intern Med 2014; 161: 491-501.
9. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-96.
10. Lipinski MJ, Baker NC, Escarcega RO, et al. Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis. Am Heart J 2015; 169: 6-16. e16.
11. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent STSegment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267-315.
12. Haaf P, Reichlin T, Twerenbold R, et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J 2014; 35: 365-75.
13. Thomas BH, Ciliska D, Dobbins M, et al. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004; 1: 176-84.
14. Koerbin G, Potter JM, AbhayaratnaWP, et al. The distribution of cardiac troponin I in a population of healthy children: lessons for adults. Clin Chim Acta 2013; 417: 54-6.
15. Eggers KM, Venge P, Lindahl B, et al. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 2013; 61: 1906-13.
16. Venge P, Johnston N, Lindahl B, et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009; 54: 1165-72.
17. de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503-12.
18. Hussein AA, Gottdiener JS, Bartz TM, et al. Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study. J Am Coll Cardiol 2013; 62: 2112-20.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
21. deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010; 304: 2494-502.
22. Eggers KM, Al-Shakarchi J, Berglund L, et al. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J 2013; 166: 541-8.
23. Oluleye OW, Folsom AR, Nambi V, et al. Investigators ASTroponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol 2013; 23: 66-73.
24. Omland T, de Lemos JA, Holmen OL, et al. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem 2015; 61: 646-56.
25. Zeller T, Tunstall-Pedoe H, Saarela O, et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014; 35: 271-81.
26. Masson S, Agabiti N, Vago T, et al. The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk. J Intern Med 2015; 277: 318-30.
27. Neumann JT, Havulinna AS, Zeller T, et al. Comparison of three troponins as predictors of future cardiovascular events: prospective results from the FINRISK and BiomaCaRE studies. PLoS One 2014; 9: e90063.
28. Wang TJ, Wollert KC, Larson MG, et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012; 126: 1596-604.
29. Thorsteinsdottir I, Aspelund T, Gudmundsson E, et al. High-sensitivity cardiac troponin I is a strong predictor of cardiovascular events and mortality in the AGES-Reykjavik community-based cohort of older individuals. Clin Chem 2016; 62: 623-30.
30. Dallmeier D, Denkinger M, Peter R, et al. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Clin Chem 2015; 61: 389-99.
31. McKie PM, AbouEzzeddine OF, Scott CG, et al. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic peptide predict heart failure and mortality in the general population. Clin Chem 2014; 60: 1225-33.
32. Sze J, Mooney J, Barzi F, et al. Cardiac troponin and its relationship to cardiovascular outcomes in community populations: a systematic review and meta-analysis. Heart Lung Circ 2016; 25: 217-28.
33. Blankenberg S, Salomaa V, Makarova N, et al. Troponin I and cardiovascular risk prediction in the general population: the Biomar- CaRE consortium. Eur Heart J 2016; 37: 2428-37.
34. Irfan A, Reichlin T, Twerenbold R, et al. Early diagnosis of myocardial infarction using absolute and relative changes in cardiac troponin concentrations. Am J Med 2013; 126: 781-8. e782.
35. Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54-61.
36. Klinkenberg LJ, Wildi K, van der Linden N, et al. Diurnal rhythm of cardiac troponin: consequences for the diagnosis of acute myocardial infarction. Clin Chem 2016; 62: 1602-11.
37. Streng AS, de Boer D, van der Velden J, et al. Posttranslational modifications of cardiac troponin T: an overview. J Mol Cell Cardiol 2013; 63: 47-56.
38. Martin AF. Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem 1981; 256: 964-8.